This finding suggests a new risk of AFB1 exposure and reveals the vital role of TLR4-induced inflammation in the promotion of SIV replication and lung damage by AFB1, pointing to TLR4 as a potential therapeutic target for preventing lethal influenza infection. Here, TLR4 is linked to influenza.